Use of medications in patients with chronic pulmonary disease.
Thompson
W L
WL
Thompson
T L
TL
D000223:Adaptation, Psychological / Q000187:drug effects; D000428:Alcohol Drinking; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001143:Arousal / Q000187:drug effects; D001986:Bronchial Spasm / Q000139:chemically induced; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D013645:Tartrazine / Q000009:adverse effects
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001993:Bronchodilator Agents; D011619:Psychotropic Drugs; D008094:Lithium; D013645:Tartrazine